Rationale and Design of the DIGIT-HF Trial (DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure): A Randomized, Double-Blind, Placebo-Controlled StudyUdo Bavendiek, Johann Bauersachs, Lars S. Maier et al.|European Journal of Heart Failure|2019Cited by 82
Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStarTakashi Yamamura, Benjamin Greenberg, Brian G. Weinshenker et al.|Multiple Sclerosis and Related Disorders|2022Cited by 60